- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Premelanosome protein (PMEL), also known as gp100 or Pmel17, is a melanosome-associated glycoprotein encoded by the PMEL gene and expressed primarily in melanocytes and melanoma cells. PMEL Antibody for IF / Premelanosome protein enables immunofluorescence visualization of this melanocyte lineage marker and supports fluorescent imaging of melanosome-associated structures within pigment-producing cells. Because PMEL localizes to developing melanosomes, immunofluorescence staining typically reveals a distinctive punctate cytoplasmic fluorescent pattern corresponding to premelanosome vesicles and early melanosome compartments in melanocytes and melanoma cells. This vesicular cytoplasmic signal reflects the intracellular distribution of melanosomes during pigment cell differentiation and makes PMEL a widely used marker for immunofluorescence analysis of melanocytic cells. Immunofluorescence microscopy using a PMEL antibody therefore provides a direct method for visualizing melanosome-associated structures and studying intracellular organelle organization in melanocytes.
PMEL Antibody for IF is particularly useful for fluorescence-based analysis because premelanosomes represent specialized intracellular vesicles that participate in the early stages of melanosome formation. PMEL is synthesized in the endoplasmic reticulum and trafficked through the Golgi and endosomal system before being delivered to premelanosomes where it undergoes proteolytic processing and structural assembly. Within these compartments, PMEL forms fibrillar matrices that provide the structural scaffold for melanin polymer deposition during melanogenesis. Immunofluorescence staining therefore highlights the distribution of these premelanosome vesicles throughout the cytoplasm of melanocytes and melanoma cells. Using fluorescent labeling, PMEL Antibody for IF reveals vesicular cytoplasmic structures that correspond to developing melanosomes and pigment-producing organelles.
Fluorescent detection of PMEL is commonly used to investigate melanosome biogenesis, intracellular trafficking, and pigment cell differentiation. In cultured melanocytes and melanoma cell models, immunofluorescence staining frequently demonstrates punctate cytoplasmic fluorescence localized near the perinuclear region and extending toward cellular projections where mature melanosomes are transported. Confocal or wide-field fluorescence microscopy can therefore be used to visualize PMEL-associated vesicles and examine the spatial distribution of premelanosomes within melanocytes. Because the gp100 protein participates in early melanosome maturation, PMEL immunofluorescence provides insight into the formation and organization of melanosome structures inside pigment-producing cells.
PMEL is widely studied as a melanocyte lineage marker and is frequently evaluated alongside other melanocyte-associated proteins such as Melan-A, tyrosinase, and MITF in melanoma research. Immunofluorescence staining using a Premelanosome protein antibody therefore supports studies of melanocyte differentiation, melanosome formation, and melanoma cell biology. PMEL fluorescence can also be incorporated into co-localization studies with other melanosome or lysosome-associated markers to evaluate intracellular trafficking pathways and organelle maturation processes. Because gp100 expression is largely restricted to melanocytes and melanocytic tumors, fluorescent detection of PMEL provides a useful approach for identifying melanocytic cells and visualizing melanosome-associated vesicles in experimental systems.
PMEL Antibody for IF / Premelanosome protein enables fluorescent visualization of gp100 within melanocytes and melanoma cells and supports immunofluorescence-based investigation of melanosome organization and pigment cell biology. Immunofluorescence microscopy using a PMEL antibody reveals the characteristic punctate cytoplasmic distribution of premelanosomes and provides a powerful tool for studying melanocyte lineage cells, intracellular melanosome structure, and melanoma-associated cellular pathways.
Optimal dilution of the PMEL Antibody for IF should be determined by the researcher.
E.coli-derived human SILV/PMEL recombinant protein (Position: H182-Q5565) was used as the immunogen for the PMEL Antibody for IF.
After reconstitution, the PMEL antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
gp100 antibody, Pmel17 antibody, Melanosome structural protein antibody, Melanocyte lineage marker antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.